Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

SB-216763 (CAS 280744-09-4)

5.0(1)
Write a reviewAsk a question

See product citations (18)

Alternate Names:
3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione
Application:
SB-216763 is a potent, selective and ATP-competitive inhibitor of GSK-3α and GSK-3β
CAS Number:
280744-09-4
Purity:
≥98%
Molecular Weight:
371.22
Molecular Formula:
C19H12Cl2N2O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

SB-216763 is a cell-permeable, potent, selective and ATP-competitive inhibitor of GSK-3 (Glycogen Synthase Kinase) with an IC50 value of 34 nM for GSK-3alpha and with similar potency for GSK-3beta. In PC-12 cells, SB-216763 exhibits neuroprotective properties and protects cultured central and peripheral nervous system neurones from cell death. Furthermore, SB-216763 increases the concentration of cytoplasmic beta-catenin through a GSK-3 dependent manner. These inhibitory effects are similar to those of Wnt. It exhibits promising anti-inflammatory properties and acts as an inhibitor of the enzyme cyclooxygenase-2 (COX-2). The compound has proven valuable in studying SB-216763 inhibition′s impact on inflammation, pain, cell proliferation, and apoptosis. Moreover, it has been employed in synthesizing organic compounds and explored for potential use in drug design.


SB-216763 (CAS 280744-09-4) References

  1. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death.  |  Cross, DA., et al. 2001. J Neurochem. 77: 94-102. PMID: 11279265
  2. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression.  |  Lochhead, PA., et al. 2001. Diabetes. 50: 937-46. PMID: 11334436
  3. GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity.  |  Culbert, AA., et al. 2001. FEBS Lett. 507: 288-94. PMID: 11696357
  4. Delayed cardioprotection afforded by the glycogen synthase kinase 3 inhibitor SB-216763 occurs via a KATP- and MPTP-dependent mechanism at reperfusion.  |  Gross, ER., et al. 2008. Am J Physiol Heart Circ Physiol. 294: H1497-500. PMID: 18223186
  5. The ceiling effect of pharmacological postconditioning with the phytoestrogen genistein is reversed by the GSK3beta inhibitor SB 216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione] through mitochondrial ATP-dependent potassium channel opening.  |  Couvreur, N., et al. 2009. J Pharmacol Exp Ther. 329: 1134-41. PMID: 19318592
  6. Novel indolylmaleimide acts as GSK-3beta inhibitor in human neural progenitor cells.  |  Schmöle, AC., et al. 2010. Bioorg Med Chem. 18: 6785-95. PMID: 20708937
  7. The first synthesis of [(11)C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3).  |  Wang, M., et al. 2011. Bioorg Med Chem Lett. 21: 245-9. PMID: 21115250
  8. Glycogen synthase kinase 3 (GSK3) inhibitor, SB-216763, promotes pluripotency in mouse embryonic stem cells.  |  Kirby, LA., et al. 2012. PLoS One. 7: e39329. PMID: 22745733
  9. [Effects of glycogen synthase kinase 3β overexpression in rat and glycogen synthase kinase 3β inhibitor SB-216763 on proliferation of hepatic oval cells].  |  Zhong, JQ., et al. 2012. Zhonghua Wai Ke Za Zhi. 50: 1003-6. PMID: 23302485
  10. Synthesis and Initial in Vivo Studies with [(11)C]SB-216763: The First Radiolabeled Brain Penetrative Inhibitor of GSK-3.  |  Li, L., et al. 2015. ACS Med Chem Lett. 6: 548-52. PMID: 26005531
  11. Inhibition of glycogen synthase kinase-3 by SB 216763 affects acquisition at lower doses than expression of amphetamine-conditioned place preference in rats.  |  Wickens, RH., et al. 2017. Behav Pharmacol. 28: 262-271. PMID: 27984209
  12. SB-216763, a GSK-3β inhibitor, protects against aldosterone-induced cardiac, and renal injury by activating autophagy.  |  Zhang, YD., et al. 2018. J Cell Biochem. 119: 5934-5943. PMID: 29600538
  13. Inhibition of GSK-3β restores delayed gastric emptying in obesity-induced diabetic female mice.  |  Sampath, C., et al. 2020. Am J Physiol Gastrointest Liver Physiol. 319: G481-G493. PMID: 32812777

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

SB-216763, 1 mg

sc-200646
1 mg
$71.00

SB-216763, 5 mg

sc-200646A
5 mg
$202.00